Geelong, Australia February 13, 2020 – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain healthy maternal and infant microbiomes, is pleased to report the publication of new research findings that link the presence of Prevotella copri in the microbiomes of 12 month old infants with reduced risk of developing anxiety-like behaviours at 24 months.
Researchers from the Barwon Infant Study (BIS) – a collaboration between Deakin University, Barwon Health and the Murdoch Children’s Research Institute (MCRI) – examined microbiome composition and behavioural data including shyness, sadness and an internal focus from 201 children, and found that children with lower levels of the bacteria P. copri had a higher prevalence of anxiety-like behaviours, an indicator of risk of developing childhood anxiety.
‘Gut microbiota composition during infancy and subsequent behavioural outcomes’ was published today in the journal EBioMedicine.
“This is an important peer reviewed publication that reiterates the role of the gut microbiome in both the structural and functional development of the brain” said Dr Greg Collier, PhD, Executive Chairman of Prevatex. “Professor Vuillermin and his colleagues from the Barwon Infant Study continue to lead the world in the study of the pivotal role of P. copri in the development of the immune system, complementing our ongoing efforts to develop and commercialise probiotic products to assist with the reduction and control of infant allergies and behaviour challenges.”